News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Results from Two Studies Demonstrate the Clinical Utility of CardioDx, Inc. Gene Expression Test in Patients with Suspected Obstructive Coronary Artery Disease



5/14/2012 9:10:10 AM

PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results of two studies evaluating the role of the Corus® CAD gene expression test in clinical decision-making for the evaluation of patients with suspected obstructive coronary artery disease (CAD). Results were presented last week at the Quality of Care and Outcomes Research (QCOR) 2012 Scientific Session in Atlanta, Ga., and the Society of General Internal Medicine (SGIM) 35th Annual Meeting in Orlando, Fla.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES